Ångström AI
YC S24 ↗San Francisco, US · Founded 2024 · 5 employees · 5 known investors
Ångström AI develops AI-powered physics simulations for pharmaceutical drug discovery, computing molecular properties like solubility, lipophilicity, and crystal structure stability to replace traditional lab experiments. The platform uses machine learning interatomic potentials and free energy calculations to accelerate and derisk solid form development for pharma companies.
AI & Machine LearningBiotechDeep TechHealthtechAI-powered Drug DiscoveryArtificial IntelligenceDrug discoveryAIin /angstrom-ai/@Angstrom_aiycombinator.com ↗
Founders & leadership· Y Combinator alumni (S24)
JM
LM
Laurence Midgleyin𝕏Founder
Investors · 5
In the news
- Ångström AI Funding | Complete Analysis | Extruct AIextruct.ai · 2024
- AI Insider Profile: Ångström AI Aims to Revolutionize Drug Discovery by Replacing Wet Lab Experiments With AI Simulationstheaiinsider.tech · 2024
- Ångström AI: Gen AI molecular simulationsycombinator.com · 2024
